RevealDx (Series A)

Funding Details
Awarder
RSS - www.geekwire.com
Date Award
August 02, 2024
Vertical
Healthcare
Funding URL
View Funding Page

Company Info
Founding Year
2021
Traction
The company has four customers in Europe and is working through FDA approval in the U.S.
Founders
Michael Calhoun, Chris Wood
Company Description
RevealDx develops software aimed at improving the way healthcare professionals diagnose lung cancer, using machine learning techniques to assess the probability that lung nodules found on chest CT scans are cancerous.
Market
Lung Cancer Diagnosis
Location
Seattle, WA, US

Links
Back to Home Back to Healthcare Deals View Funding Announcement